MBRS-71. ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN ATTENUATES DNA DAMAGE AND IS A THERAPEUTIC TARGET IN Myc-DRIVEN MEDULLOBLASTOMA

Group 3 medulloblastoma tumors (Myc-MB), and particularly the 3γ subtype, have the worst prognosis and show a 5-year overall survival of less than 40%. Group 3 tumors are often accompanied by Myc amplification and have a higher rate of metastatic disease and relapse. Unfortunately, therapeutic strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Hafiz, Ahmed, Madhavan, Krishna, Balakrishnan, Ilango, Pierce, Angela, Wang, Dong, Danis, Etienne, Serkova, Natalie, Venkataraman, Sujatha, Vibhakar, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Research)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715361/
http://dx.doi.org/10.1093/neuonc/noaa222.575

Ejemplares similares

Ejemplares similares